In preclinical models of TBI, the murine version of PNT001, mPNT001, prevented a range of neuropathological outcomes, including axonal pathology, astrogliosis, tau oligomerization, NFT formation, and brain atrophy [192–195]. Here, MAPT is linked to Brain atrophy.